Is HealthStream (HSTM) a Better Healthcare Bet Than Humana (HUM) Right Now?
Humana (HUM) and HealthStream (HSTM) partnered to expand caregiver training. Humana reported Q2 2026 adjusted EPS of $7.61, lowering FY GAAP EPS guidance to $6.52. HealthStream saw Q2 revenue rise 12.5% to $83.7M, with net income up 23.8%. Humana faces regulatory pressures, while HealthStream benefits from strong margins and a debt-free balance sheet.
How this was made
The 30-second read
Why it matters
Humana's guidance cut may trigger a sell‑off, while HealthStream's record results could attract buying interest.
Market read
Earnings releases for two publicly traded healthcare companies provide fresh data for traders to adjust positions.
What to watch
Humana's Medicaid partnership with HealthStream may create longer‑term synergies not reflected in the short‑term earnings miss.
Background
The article compares Q2 2026 earnings and outlook for Humana (a large insurer) and HealthStream (a health‑tech SaaS provider).
Ticker impact
Humana reported Q2 2026 GAAP EPS of $5.73, adjusted EPS $7.61 and lowered FY GAAP EPS guidance to at least $6.52.
Potential short-term downside as investors reassess margin outlook.
Guidance cut and high benefit ratio signal earnings pressure.
HealthStream posted Q2 2026 revenue of $83.7 M, operating income $8.3 M and net income $6.7 M, beating prior expectations.
Likely upside as investors reward growth and leverage improvement.
Record revenue growth and margin expansion indicate momentum.
Market effects
Both companies highlight divergent trends in healthcare services vs. health‑tech software.
U.S. healthcare sector may see mixed reactions as insurers and SaaS providers diverge.
Limited to U.S. markets; no immediate global macro impact.
Counterpoint
HealthStream's small‑cap size could expose it to customer concentration risk despite strong earnings.
Key entities
- companyHumana Inc.
U.S. health insurance provider.
- companyHealthStream, Inc.
Provider of workforce training software for healthcare.
